Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BCL2 associated transcription factor 1 pseudogene 2 (BCLAF1P2) is classified as a pseudogene, meaning it is a segment of DNA that resembles a gene but generally does not encode a functional protein[7]. The entry has external IDs such as HGNC: 51807, NCBI Gene: 731605, Ensembl: ENSG00000279800[7]. There is no evidence in current biomedical literature indicating that BCLAF1P2 produces a functional protein, acts as a therapeutic target, or plays a direct role in human disease or physiology. Its designation as a pseudogene distinguishes it from BCLAF1, which is a well-characterized transcription factor involved in apoptosis, cancer, mRNA splicing, and other processes[1][3][5]. No drugs, mechanisms of action, biomarker roles, or safety issues are associated with BCLAF1P2[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BCL2 associated transcription factor 1 pseudogene 2 (BCLAF1P2).